Jianfeng Group Pro 2015-022 (Announcement of Resolutions of the 4th Session of the 9th Board of Directors)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 No.: Pro 2015-022
Bond Abbreviations: 13 Peak 01 Bond Code: 122227
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement of Resolutions of the Fourth Session of the Ninth Board of Directors
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the relevant provisions of the company's Articles of Association.
(II) 2015# On August 14, 38, the company issued the notice of the board meeting by fax, e-mail and personal delivery.
(III) 2015# On August 26, 42, the board meeting was held by means of on-site voting combined with communication. The on-site meeting was held in the conference room on the third floor of Jianfeng Building, Jinhua City, Zhejiang Province.
(IV) 9directors should attend this board meeting and 9 directors actually attended the meeting, of which 4 directors, Wu Xiaoming, Huang Sujian, Wu Guanghui and Zhu Linming, voted by communication.
(V) The board of directors was presided over by Chairman Jiang Xiaomeng, and the company's supervisors and senior management attended the meeting.2. Board Meeting Review
1
, 2015 Semi-annual Report
The Board of Directors reviewed and approved the report.Voting result: 9
votes in favor, 0 votes against and 0 abstentions. The full text and summary of the semi-annual report of
2015can be found on the website of Shanghai Stock Exchange (www.sse.com.cn ).
2, Proposal on Adding Independent Directors
August 12, 2015, Mr. Zhang Yuyou, an independent director of the company, submitted a written resignation report to the company. In accordance with the China Securities Regulatory Commission's "Guiding Opinions on Establishing an Independent Director System in Listed Companies" and the company's "Articles of Association" and other relevant regulations, the company's board of directors nominated Mr. Huang Congyun as an independent director candidate of the company. The board of directors reviewed and approved the proposal. Mr. Huang Congyun will be submitted as an independent director candidate of the company to the first extraordinary general meeting of shareholders in 2015
.Voting result: 9
votes in favor, 0 votes against and 0 abstentions.Independent directors expressed their independent opinions as follows:
(I) that the candidates for independent directors nominated this time have independence and the work experience necessary to perform the duties of independent directors, in line with the provisions of the guidance on the Establishment of Independent Director system in listed companies, the Governance Standards of listed companies and the articles of Association of the company, the nomination procedure is legal and effective;
The (II) did not find that independent director candidates are not allowed to serve as independent directors of the company as stipulated in the "Company Law", the company's "Articles of Association" and the "Guiding Opinions on Establishing an Independent Director System in Listed Companies". Circumstances that have been confirmed as market bans by the China Securities Regulatory Commission and the ban has not been lifted;
The (III) agreed that the board of directors nominated Mr. Huang Congyun as an independent director candidate for the ninth board of directors of the company and submitted
for the election of the first extraordinary general meeting of shareholders in 2015. 3
, Proposal on Formulating the "Jianfeng Group Medium and Long-term Incentive Management Measures"The board of directors reviewed and approved the proposal, and the proposal will be submitted to 2015
The first extraordinary general meeting of shareholders deliberated. Mr. Jiang Xiaomeng and Mr. Yu Jianhong, the directors, avoided voting on the motion.voting result: 7
votes in favor, 0 votes against and 0 abstentions."Jianfeng Group Medium and Long-term Incentive Management Measures" can be found on the website of Shanghai Stock Exchange (www.sse.com.cn
).Independent Directors expressed their independent opinions as follows:
We
believe that the formulation of the "Medium and Long-term Incentive Management Measures" by the company is conducive to the stability and development of key employees, fully mobilize the enthusiasm of middle and senior management personnel, business backbones and key employees at all levels of the company, and realize the sustainable, stable and healthy development of the company. The formation of this resolution complies with the "Company Law", the company's "Articles of Association" and other relevant provisions, and does not harm the interests of small and medium shareholders. 4
, Proposal on Convening the First Extraordinary General Meeting of Shareholders in 2015The Board of Directors decided to convene the first extraordinary general meeting of shareholders in 2015
on September 14, 2015.voting results: 9
votes, 0 votes against, 0 abstentionsPlease refer to the Notice on Convening the First Extraordinary General Meeting of 2015
(P.2015 -023).Annex to 3. Online Announcement (if applicable)
the opinions of independent directors of the company on the above related matters.
is hereby announced.
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
August 28, 2015
Independent Director Candidate Resume:
Mr. Huang Congyun, 1963# Born in March 177, Doctor of Engineering, he is currently a professor at the School of Materials Science and Engineering, Wuhan University of Technology, and a professor at the State Key Laboratory of Silicate Building Materials. He is also the deputy director of the Science and Education Committee of the Hubei Provincial Committee of the China Democratic National Construction Association, the deputy chairman of the Committee of the Wuhan University of Technology of the China Democratic National Construction Association, the expert member of the National Cement Standardization Technical Committee, the executive director of the Cement Grinding Aid Association, and the "Cement Equipment Technology" and "Cement Grinding Aid" magazine consultant Wait.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page